Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/12/2003WO2002054044A3 Focused acoustic ejection cell sorting system and method
06/12/2003WO2002018544A3 Method and reagents for treatment of skin disorders by modulating the notch pathway
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2002008389A9 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030110539 Eustoma having deformed pistil and method for breeding the same
06/12/2003US20030110538 Genetic engineered mitochondria, chloroplast; hybrids
06/12/2003US20030110535 Transforming gene using enzyme; potatoes; discoloration inhibition
06/12/2003US20030110534 Monocotyledon plant cells and plants which synthesise modified starch
06/12/2003US20030110533 Acetyl-CoA carboxylase subunits
06/12/2003US20030110529 Genetic engineering gene expression cassette; adjustment protein cell cycles; plants
06/12/2003US20030110528 Novel ecdysone receptors and methods for their use
06/12/2003US20030110521 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription
06/12/2003US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders
06/12/2003US20030109693 Chondroitin polymerase and DNA encoding the same
06/12/2003US20030109685 Schizophrenic, psychological disorders, Parkinson's disease; genetic engineered polypeptide
06/12/2003US20030109683 Hybrid proteins; controlling gene expression in gene therapy; Parkinson's disease
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109677 TIE-2 ligands, methods of making and uses thereof
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109672 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030109670 Conotoxins; sodium channel moderators, calcium channel blockers, analgesics
06/12/2003US20030109481 Tumour-cell specific gene expression and its use in cancer therapy
06/12/2003US20030109477 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/12/2003US20030109474 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and
06/12/2003US20030109468 Novel compounds that enhance dimerization of the subunits of HIV-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors
06/12/2003US20030109465 TGF- beta blocking agent-treated HSC compositions and methods comprising the same. The TGF- beta blocking agent-treated stem cells are viable for an extended time in culture without replication or differentiation and upon transfer to conditions
06/12/2003US20030109452 Containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
06/12/2003US20030109438 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/12/2003US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells
06/12/2003US20030109430 Immunoassays for human and canine brain natriuretic peptide
06/12/2003US20030109043 Culture product; plant growth regulators; plant for antipyretic therapy
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030109041 Culture regeneration of nervous systems; cell differentiation; wound healing agent
06/12/2003US20030109040 Optical cell guidance method and apparatus
06/12/2003US20030109039 Enriched central nervous system stem cell and porgenitor cell populations, and methods for identifying, isolating and enriching for such populations
06/12/2003US20030109038 Chondrocyte precursors derived from human embryonic stem cells
06/12/2003US20030109037 Central nervous system disorders
06/12/2003US20030109036 Pancrea cells; antidiabetic agents
06/12/2003US20030109035 Cell differentiation; tissue engineering; using activin, retinoic acid culture product
06/12/2003US20030109034 Digestion of tissue blocks using enzymes
06/12/2003US20030109027 Tumor suppression genes
06/12/2003US20030109023 HIV-producing cell line and uses thereof
06/12/2003US20030109022 Asp2
06/12/2003US20030109018 Novel endometriosis-associated gene
06/12/2003US20030109016 Tumor suppresison gene; anticancer agents
06/12/2003US20030109013 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid
06/12/2003US20030109008 Cell proliferation, cell differentiation; stem cells
06/12/2003US20030109006 Isolation of lymphocytes, binding, forming culture product, cloning
06/12/2003US20030109004 Culture product; cell transformation; genetic engineering using promoter
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108993 Human mitochondrial chaperone protein
06/12/2003US20030108983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030108971 Enzyme
06/12/2003US20030108968 Determination lymphocytes to specific antigen in blood
06/12/2003US20030108967 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108963 Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
06/12/2003US20030108954 Focusing sound waves
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108942 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
06/12/2003US20030108941 Novel cancer drug screen based on cell cycle uncoupling
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108929 Diagnosis of Alzheimer's disease
06/12/2003US20030108923 Blocking gene expression
06/12/2003US20030108907 Nucleic acids, proteins, and antibodies
06/12/2003US20030108889 Mutations; cloning; immunoglobulins; genetic engineering
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/12/2003US20030108877 Methods for selecting and producing selective pharmaceutical compounds and compositions using an established genetically altered cell-based library responsive to transcription factors; genetic constructs and library therefor.
06/12/2003US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
06/12/2003US20030108861 Comprises serum-free culture; protease-free
06/12/2003US20030108860 Growing high density culture (serum-free) of adherent cells bound to microcarrier (dextran), infecting cells, then incubating
06/12/2003US20030108858 Methods for the simultaneous detection of HCV antigens and HCV antibodies
06/12/2003US20030108642 Penicillium funiculosum strain useful for the production of enzymes
06/12/2003US20030108574 Carbohydrate-based whole cell cancer vaccines
06/12/2003US20030108560 Chimeric filovirus glycoprotein
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108557 Biosynthesis; contacting plant cell with genetic engineered nucleic acid virus; gene expression of fusion protein; splitting using cyanogen bromide
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108552 Genetic engineered polypeptides; rheumatic diseases, sepsis, viricides
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108536 Therapy for bone marrow diseases; bubbing ozone, irradiation with ultraviolet radiation; antiinflammatory agents
06/12/2003US20030108535 Administering pluripotent cells
06/12/2003US20030108534 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
06/12/2003US20030108533 Mediators of signal transduction
06/12/2003US20030108531 Genes for transfection into bony tissues
06/12/2003US20030108529 Cell coated surfaces; calibrating reduction in phosphorylation
06/12/2003US20030108527 Maturation-promoting agent for immature dendrtic cells
06/12/2003US20030108521 Adenovirus protein IX, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
06/12/2003DE10127008C1 Population of neuronal cells containing receptors but not expressing neurotransmitters, useful e.g. in drug screening and as transplants for treating neurodegeneration
06/12/2003CA2847885A1 Transgenic animals bearing human ig.lambda. light chain genes
06/12/2003CA2811997A1 Antibodies against monocyte chemotactic proteins
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 1827